Motrin maker sued over inadequate warnings of rare side effect
A Texas woman is suing the manufacturers of Motrin after her daughter suffered a rare side effect of the drug and was hospitalized for over a month.
Keshia Hunt, individually and on behalf of her minor child, filed suit against McNeil Consumer Healthcare and Johnson & Johnson on Feb. 24 in federal court in New Orleans.
According to the complaint, Hunt's daughter took Motrin on Feb. 4, 2010 and was admitted to the emergency room with a severe rash. The child was admitted to the hospital and was subsequently diagnosed with severe Stevens-Johnson-Syndrome and/or Toxic Epidermal Necrolysis. She remained in the hospital for over a month, the suit says.
Hunt accuses the defendant of failing to adequately test the drug and failing to adequately report clinical trial data. Hunt also states that there was a safer alternative design which would have prevented or reduced the risk to the child, and that design was economically and technologically feasible.
The drug was unreasonably dangerous and had defective characteristics due to inadequate warning of risks, the lawsuit claims.
The plaintiff is seeking damages for medical expenses, physical pain and suffering, mental anguish, physical disfigurement, physical impairment, interest, court costs and interest.
Hunt is represented by Robert L. Salim of Law Office of Robert L. Salim in Natchitoches and Terrence J. Lestelle of Lestelle & Lestelle in Metairie. A jury trial is requested.
U.S. District Judge A. J. McNamara is assigned to the case.
Case No. 2:11-cv-00457